Submit a manuscript Sign up for article alerts Contact us Support

About Thrombosis Journal

This page includes information about the aims and scope of Thrombosis Journal, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Thrombosis Journal is a peer-reviewed, online, open access journal that aims to publish biologically significant findings with clinical relevance in the field of acute and chronic vascular thrombotic disease.

Thrombosis Journal is aimed at the field of thrombotic diseases. The journal publishes original articles on aspects of clinical and basic research, new methodology, case reports and review in the areas of thrombosis (platelets, coagulation fibrinolysis and vessel wall, risk factors for thrombosis and atherosclerosis) and related pathologies such as dyslipemia, hypertension, diabetes, immunology and obesity.

Thrombosis Journal considers manuscripts on the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between hemostasis and vascular disease.

As an open access journal, readers can freely obtain the latest news in the field of thrombosis, and authors benefit from no page restrictions and no limits to tables or figures, making publication more complete and more comprehensive.

Open access

All articles published by Thrombosis Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Thrombosis Journal are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Thrombosis Journal therefore levies an article-processing charge of £1240/$1940/€1580 for each article accepted for publication. If the corresponding author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Thrombosis Journal are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Thrombosis Journal include:

  • CAS
  • Citebase
  • DOAJ
  • Embase
  • Google Scholar
  • OAIster
  • PubMed
  • PubMed Central
  • SCImago
  • Scopus
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Thrombosis Journal will be available.

Publication and peer review process

Criteria for publication

Thrombosis Journal considers the following types of articles:

Original clinical investigation: full articles on human investigation, including brief communications.

Original basic research articles: full articles on basic research (in vivo and in vitro) including brief communications.

Reviews: articles can be submitted upon specific invitation or editorial acceptance of an author's proposal; these may include short-reviews on specific topics.

Latest therapeutic developments: discussion on the clinical value of new drugs giving an indication of their potential application, mechanism of action, doses, side effects and cost/benefit; these include drugs under development (Phase II and Phase III) and postmarketing (Phase IV) of drugs already approved and available but found to have new action, or indications in the pharmaceutical markets of different countries.

Case reports: reports of cases that can be used for educational purposes or adverse effects of drugs or relevant positive and negative findings.

Book reviews: short summaries of the strengths and weaknesses of a book. They should evaluate its overall usefulness to the intended audience.

Peer-review policies

  • Peer review in Thrombosis Journal is designed to ensure that the research published is 'good science'.
  • submitted manuscripts will generally be reviewed by one member of the Editorial Board and two external experts. Statistical methodology will also be reviewed.
  • After receiving the manuscript, a member of the Editorial Board will be assigned to oversee the peer review process.
  • Peer reviewers should be suggested by authors, and the editorial office will aim to honour such proposals.
  • Peer reviewers will have four possible options, for each article: 1) accept without revision; 2) accept after revision without expecting to check those revisions; 3) neither accept nor reject until author(s) make revisions and resubmit; 4) reject because scientifically unsound.
  • We aim to publish research as quickly as possible. Our electronic submission process is designed to facilitate rapid publication.

Edited by Raul Altman, Thrombosis Journal is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Thrombosis Journal, a personalized section of the site.


High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.


Thrombosis Journal will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Thrombosis Journal should adhere to BioMed Central's editorial policies.

Citing articles in Thrombosis Journal

Articles in Thrombosis Journal should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Thrombosis J [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Thrombosis J 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Thrombosis Journal?

High visibility

Thrombosis Journal's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Thrombosis Journal offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Thrombosis Journal, BioMed Central and PubMed Central and will also be included in PubMed.


Online publication in Thrombosis Journal gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Thrombosis Journal are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Thrombosis Journal's pages and on the BioMed Central homepage.

In addition, articles published in Thrombosis Journal may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Thrombosis Journal. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Thrombosis Journal retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.